B855 (Repaglinide 2 mg)
Pill with imprint B855 is Red, Round and has been identified as Repaglinide 2 mg. It is supplied by Breckenridge Pharmaceutical, Inc..
Repaglinide is used in the treatment of diabetes, type 2 and belongs to the drug class meglitinides. Risk cannot be ruled out during pregnancy. Repaglinide 2 mg is not a controlled substance under the Controlled Substances Act (CSA).
Images for B855
Repaglinide
- Imprint
- B855
- Strength
- 2 mg
- Color
- Red
- Shape
- Round
- Availability
- Prescription only
- Drug Class
- Meglitinides
- Pregnancy Category
- C - Risk cannot be ruled out
- CSA Schedule
- Not a controlled drug
- Labeler / Supplier
- Breckenridge Pharmaceutical, Inc.
- National Drug Code (NDC)
- 51991-0855
Related Images for "B855"
More about repaglinide
- Side Effects
- During Pregnancy or Breastfeeding
- Dosage Information
- Drug Images
- Drug Interactions
- Pricing & Coupons
- En Español
- 10 Reviews
- Drug class: meglitinides
Consumer resources
- Other brands
- Prandin
Professional resources
Related treatment guides
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.